 LOS ANGELES, Aug. 23, 2021 GLOBE NEWSWIRE -- NASDAQ: ENOB Enochian BioSciences, a company focused on gene modified cellular and immune therapies for infectious diseases and cancer, announced that the renowned Dr. Anna Suk-Fong Lok, MD, has joined the Scientific Advisory Board for a potential cure for Hepatitis B Virus HBV, that causes liver disease in approximately 350 million people globally and 1 million deaths every year. 